CML BCR-ABL1 Detection Solution

The BCR-ABL1 dPCR solution provides ultra-sensitive, absolute quantification of fusion transcripts, outperforming qPCR in precision for low-level detection (e.g., MR4.5 ≤0.0032%). With ≥4.5-log sensitivity, it reliably assesses DMR to guide TKI therapy and TFR decisions while monitoring MRD. Its calibration-free absolute quantification reduces variability, enhancing reproducibility in low-burden CML monitoring.

Overview

Ordering Information

Resources

Key Advantages and Benefits

1. Effortless Operation

One-step loading, automated processing – Simply load the PCR reaction into the chip, and the system handles droplet generation and amplification seamlessly, minimizing hands-on time.

2. Absolute Quantification

Standard curve-free quantification – Precisely measure BCR-ABL and ABL transcript levels without the need for calibration curves.

3. Ultra-Sensitive & Highly Reproducible

Detection sensitivity down to MR4.7 – Achieve reliable, repeatable results even at minimal residual disease (MRD) levels.

4. IS-Compliant Reporting

IS (International Scale) reporting – Generate standardized, globally recognized BCR-ABL expression results with no additional conversion.

Workflow

Ordering Information

Catalog No.	Product Name	Specification	Description
H121027048	BCR-ABL %IS Digital PCR Detection Kit	48r	Chip matched

We have a variety of reference materials available, including colour brochures, technical guides, professional literature and operation videos. If you need to consult or obtain relevant materials, please fill in the information below to contact us.

CML BCR-ABL1 Detection Solution

Key Advantages and Benefits

Workflow

Ordering Information

AML NPM1/FLT3/IDH Detection Solution

Mutation-Targeted Testing